# A Trial Of SU14813 In Patients With Advanced Solid Malignancies

> **NCT00982267** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 77 (actual)

## Conditions studied

- Neoplasms
- Solid Tumors

## Interventions

- **DRUG:** SU014813

## Key facts

- **NCT ID:** NCT00982267
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2008-11
- **Final completion:** 2011-06
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2011-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982267, "A Trial Of SU14813 In Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00982267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*